Jeddah Health Cluster Two signs a cooperation agreement with Jamjoom Pharma to enhance healthcare
Jeddah Health Cluster Two has signed a strategic cooperation agreement with Jamjoom Pharma, one of the most prominent Saudi companies specializing in the pharmaceutical and healthcare sector. This partnership aims to enhance the level of health services provided to citizens and residents in the Kingdom of Saudi Arabia.
The agreement focuses primarily on raising health awareness in the community by launching joint awareness programs aimed at educating individuals on methods of disease prevention. The initiative also seeks to improve the quality of healthy life in line with the goals of Saudi Vision 2030, which places human health at the forefront of its priorities.
In addition to the awareness aspect, the agreement includes plans to develop the professional capabilities of the medical staff working within the health cluster. This will be achieved through organizing training workshops and exchanging scientific and technical expertise between the two parties, which contributes to raising the efficiency of medical services provided at the cluster's facilities.
This step comes within the framework of the Saudi Ministry of Health's continuous efforts to strengthen partnerships with the private sector, with the aim of supporting innovation in healthcare and providing advanced medical solutions. It is expected that these collaborations will contribute to improving the patient experience and facilitating their access to the best therapeutic and pharmaceutical services.
In conclusion, this agreement reflects the commitment of national institutions to developing the health sector in the Kingdom. By integrating the expertise of the private sector with the infrastructure of health clusters, the Kingdom is moving with steady steps towards building a sustainable and comprehensive health system that serves all members of society.